Klinične študije za Lupus v Michigan
10 študij za Lupus išče udeležence na lokacijah v Michigan.
Mesta v Michigan
Uradno besedilo študije (angleško)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50219, Detroit
Vključevanje udeležencevFaza 3
Starost 16 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- AA MRC LLC - Grand Blanc, Grand Blanc
- June DO, PC, Lansing
Vključevanje udeležencevFaza 2
Starost 18–74 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Henry Ford Health, Detroit
- Ahmed Arif Medical Research Center, Grand Blanc
Vključevanje udeležencevFaza 3
Starost 12–100 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06133972A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Revive Research Institute, Sterling Heights
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07438496A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Oakland Hills Dermatology, Auburn Hills
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07355218A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Revival Research Institute, LLC, Troy
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07332481A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0034, Ann Arbor
- AA MRC, Grand Blanc
Vključevanje udeležencevOpazovalna študija
Starost 16 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07175285A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
- Revive Research Institute, LLC, Sterling Heights
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT07201129A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Flint
- Investigative Site, Troy
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07260877Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
- University of Michigan, Ann Arbor
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 11. maj 2026 · NCT06208514Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.